We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Erenumab
Australian Public Assessment Report
Device/Product Name
Aimovig
Active ingredients
Erenumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-02174-1-1
Submission Type
New biological entity
Decision
Approved